Sequential bottlenecks drive viral evolution in early acute hepatitis C virus infection
Rowena A Bull, Fabio Luciani, Kerensa McElroy, Silvana Gaudieri, Son T Pham, Abha Chopra, Barbara Cameron, Lisa Maher, Gregory J Dore, Peter A White, Andrew R Lloyd, Rowena A Bull, Fabio Luciani, Kerensa McElroy, Silvana Gaudieri, Son T Pham, Abha Chopra, Barbara Cameron, Lisa Maher, Gregory J Dore, Peter A White, Andrew R Lloyd
Abstract
Hepatitis C is a pandemic human RNA virus, which commonly causes chronic infection and liver disease. The characterization of viral populations that successfully initiate infection, and also those that drive progression to chronicity is instrumental for understanding pathogenesis and vaccine design. A comprehensive and longitudinal analysis of the viral population was conducted in four subjects followed from very early acute infection to resolution of disease outcome. By means of next generation sequencing (NGS) and standard cloning/Sanger sequencing, genetic diversity and viral variants were quantified over the course of the infection at frequencies as low as 0.1%. Phylogenetic analysis of reassembled viral variants revealed acute infection was dominated by two sequential bottleneck events, irrespective of subsequent chronicity or clearance. The first bottleneck was associated with transmission, with one to two viral variants successfully establishing infection. The second occurred approximately 100 days post-infection, and was characterized by a decline in viral diversity. In the two subjects who developed chronic infection, this second bottleneck was followed by the emergence of a new viral population, which evolved from the founder variants via a selective sweep with fixation in a small number of mutated sites. The diversity at sites with non-synonymous mutation was higher in predicted cytotoxic T cell epitopes, suggesting immune-driven evolution. These results provide the first detailed analysis of early within-host evolution of HCV, indicating strong selective forces limit viral evolution in the acute phase of infection.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
References
- The Global Burden Of Hepatitis CWG. Global burden of disease (GBD) for hepatitis C. J Clin Pharmacol. 2004;44:20–29.
- Ascione A, Tartaglione T, Di Costanzo GG. Natural history of chronic hepatitis C virus infection. Dig Liv Dis. 2007;39(Suppl 1):S4–7.
- Bowen D, Walker C. Adaptive immune responses in acute and chronic hepatitis C virus infection. Nature. 2005;436:946–952.
- Post J, Ratnarajah S, Lloyd AR. Immunological determinants of the outcomes from primary hepatitis C infection. Cell Mol Life Sci. 2009;66:733–756.
- Strickland G, El-Kamary S, Klenerman P, Nicosia A. Hepatitis C vaccine: supply and demand. Lancet Infect Dis. 2008;8:379–386.
- Maher L, White B, Hellard M, Madden A, Prins M, et al. Candidate hepatitis C vaccine trials and people who inject drugs: challenges and opportunities. Vaccine. 2010;28:7273–7278.
- Torresi J, Johnson D, Wedemeyer H. Progress in the development of preventive and therapeutic vaccines for hepatitis C virus. J Hepatol. 2011;54:1273–1285.
- Sanjuan R, Moya A, Elena SF. The distribution of fitness effects caused by single-nucleotide substitutions in an RNA virus. Proc Natl Acad Sci U S A. 2004;101:8396–8401.
- Neumann AU, Lam NP, Dahari H, Gretch DR, Wiley TE, et al. Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy. Science. 1998;282:103–107.
- Guedj J, Rong L, Dahari H, Perelson AS. A perspective on modelling hepatitis C virus infection. J Viral Hepat. 2010;17:825–833.
- Duffy S, Shackelton LA, Holmes EC. Rates of evolutionary change in viruses: patterns and determinants. Nat Rev Genet. 2008;9:267–276.
- Elena SF, Sanjuán R. Virus evolution: insights from an experimental approach. Annu Rev Ecol Evol Syst. 2007;38:27–52.
- Boutwell CL, Rolland MM, Herbeck JT, Mullins JI, Allen TM. Viral evolution and escape during acute HIV-1 infection. J Infect Dis. 2010;202(Suppl 2):S309–314.
- Bar KJ, Li H, Chamberland A, Tremblay C, Routy JP, et al. Wide variation in the multiplicity of HIV-1 infection among injection drug users. J Virol. 2010;84:6241–6247.
- Keele BF, Giorgi EE, Salazar-Gonzalez JF, Decker JM, Pham KT, et al. Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection. Proc Natl Acad Sci U S A. 2008;105:7552–7557.
- Kouyos RD, Althaus CL, Bonhoeffer S. Stochastic or deterministic: what is the effective population size of HIV-1? Trends Microbiol. 2006;14:507–511.
- Koelle K, Cobey S, Grenfell B, Pascual M. Epochal evolution shapes the phylodynamics of interpandemic influenza A (H3N2) in humans. Science. 2006;314:1898–1903.
- Sheridan I, Pybus OG, Holmes EC, Klenerman P. High-resolution phylogenetic analysis of hepatitis C virus adaptation and its relationship to disease progression. J Virol. 2004;78:3447–3454.
- Farci P, Shimoda A, Coiana A, Diaz G, Peddis G, et al. The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies. Science. 2000;288:339–344.
- Shankarappa R, Margolick JB, Gange SJ, Rodrigo AG, Upchurch D, et al. Consistent viral evolutionary changes associated with the progression of human immunodeficiency virus type 1 infection. J Virol. 1999;73:10489–10502.
- Goonetilleke N, Liu MK, Salazar-Gonzalez JF, Ferrari G, Giorgi E, et al. The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection. J Exp Med. 2009;206:1253–1272.
- Salazar-Gonzalez JF, Salazar MG, Keele BF, Learn GH, Giorgi EE, et al. Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection. J Exp Med. 2009;206:1273–1289.
- Margulies M, Egholm M, Altman WE, Attiya S, Bader JS, et al. Genome sequencing in microfabricated high-density picolitre reactors. Nature. 2005;437:376–380.
- Wang C, Mitsuya Y, Gharizadeh B, Ronaghi M, Shafer RW. Characterization of mutation spectra with ultra-deep pyrosequencing: application to HIV-1 drug resistance. Genome Res. 2007;17:1195–1201.
- Wang GP, Ciuffi A, Leipzig J, Berry CC, Bushman FD. HIV integration site selection: analysis by massively parallel pyrosequencing reveals association with epigenetic modifications. Genome Res. 2007;17:1186–1194.
- Hoffmann C, Minkah N, Leipzig J, Wang G, Arens MQ, et al. DNA bar coding and pyrosequencing to identify rare HIV drug resistance mutations. Nucleic Acids Res. 2007;35:e91.
- Le T, Chiarella J, Simen BB, Hanczaruk B, Egholm M, et al. Low-abundance HIV drug-resistant viral variants in treatment-experienced persons correlate with historical antiretroviral use. PLoS One. 2009;4:e6079.
- Tsibris AM, Korber B, Arnaout R, Russ C, Lo CC, et al. Quantitative deep sequencing reveals dynamic HIV-1 escape and large population shifts during CCR5 antagonist therapy in vivo. PLoS One. 2009;4:e5683.
- Johnson JA, Li JF, Wei X, Lipscomb J, Irlbeck D, et al. Minority HIV-1 drug resistance mutations are present in antiretroviral treatment-naive populations and associate with reduced treatment efficacy. PLoS Med. 2008;5:e158.
- Wang GP, Sherrill-Mix SA, Chang KM, Quince C, Bushman FD. Hepatitis C virus transmission bottlenecks analyzed by deep sequencing. J Virol. 2010;84:6218–6228.
- Solmone M, Vincenti D, Prosperi MC, Bruselles A, Ippolito G, et al. Use of massively parallel ultradeep pyrosequencing to characterize the genetic diversity of hepatitis B virus in drug-resistant and drug-naive patients and to detect minor variants in reverse transcriptase and hepatitis B S antigen. J Virol. 2009;83:1718–1726.
- Margeridon-Thermet S, Shulman NS, Ahmed A, Shahriar R, Liu T, et al. Ultra-deep pyrosequencing of hepatitis B virus quasispecies from nucleoside and nucleotide reverse-transcriptase inhibitor (NRTI)-treated patients and NRTI-naive patients. J Infect Dis. 2009;199:1275–1285.
- Wright CF, Morelli MJ, Thebaud G, Knowles NJ, Herzyk P, et al. Beyond the consensus: dissecting within-host viral population diversity of Foot-and-Mouth Disease Virus by using next-generation genome sequencing. J Virol. 2011;85:2266–2275.
- Zagordi O, Klein R, Daumer M, Beerenwinkel N. Error correction of next-generation sequencing data and reliable estimation of HIV quasispecies. Nucleic Acids Res. 2010;38:7400–7409.
- Farci P, Purcell RH. Clinical significance of hepatitis C virus genotypes and quasispecies. Semin Liver Dis. 2000;20:103–126.
- Zagordi O, Geyrhofer L, Roth V, Beerenwinkel N. Deep sequencing of a genetically heterogeneous sample: local haplotype reconstruction and read error correction. J Comput Biol. 2010;17:417–428.
- Timm J, Lauer GM, Kavanagh DG, Sheridan I, Kim AY, et al. CD8 epitope escape and reversion in acute HCV infection. J Exp Med. 2004;200:1593–1604.
- Cox AL, Mosbruger T, Lauer GM, Pardoll D, Thomas DL, et al. Comprehensive analyses of CD8+ T cell responses during longitudinal study of acute human hepatitis C. Hepatology. 2005;42:104–112.
- Cox AL, Mosbruger T, Mao Q, Liu Z, Wang XH, et al. Cellular immune selection with hepatitis C virus persistence in humans. J Exp Med. 2005;201:1741–1752.
- Chen S, Wang YM. Evolutionary study of hepatitis C virus envelope genes during primary infection. Chin Med J (Engl) 2007;120:2174–2180.
- Ray SC, Fanning L, Wang XH, Netski DM, Kenny-Walsh E, et al. Divergent and convergent evolution after a common-source outbreak of hepatitis C virus. J Exp Med. 2005;201:1753–1759.
- Teutsch S, Luciani F, Scheuer N, McCredie L, Hosseiny P, et al. Incidence of primary hepatitis C infection and risk factors for transmission in an Australian prisoner cohort. BMC Public Health. 2010;10:633.
- Dolan K, Teutsch S, Scheuer N, Levy M, Rawlinson W, et al. Incidence and risk for acute hepatitis C infection during imprisonment in Australia. Eur J Epidemiol. 2010;25:143–148.
- Giorgi EE, Funkhouser B, Athreya G, Perelson AS, Korber BT, et al. Estimating time since infection in early homogeneous HIV-1 samples using a poisson model. BMC Bioinformatics. 11:532.
- Lee HY, Giorgi EE, Keele BF, Gaschen B, Athreya GS, et al. Modeling sequence evolution in acute HIV-1 infection. J Theor Biol. 2009;261:341–360.
- Drummond AJ, Rambaut A, Shapiro B, Pybus OG. Bayesian coalescent inference of past population dynamics from molecular sequences. Mol Biol Evol. 2005;22:1185–1192.
- Zhang P, Zhong L, Struble EB, Watanabe H, Kachko A, et al. Depletion of interfering antibodies in chronic hepatitis C patients and vaccinated chimpanzees reveals broad cross-genotype neutralizing activity. Proc Natl Acad Sci U S A. 2009;106:7537–7541.
- Owsianka AM, Timms JM, Tarr AW, Brown RJ, Hickling TP, et al. Identification of conserved residues in the E2 envelope glycoprotein of the hepatitis C virus that are critical for CD81 binding. J Virol. 2006;80:8695–8704.
- Ruhl M, Knuschke T, Schewior K, Glavinic L, Neumann-Haefelin C, et al. The CD8+ T-Cell Response Promotes Evolution of Hepatitis C Virus Nonstructural Proteins. Gastroenterology. 2011;140:2064–2073.
- Merani S, Petrovic D, James I, Chopra A, Cooper D, et al. Effect of immune pressure on hepatitis C virus evolution: insights from a single-source outbreak. Hepatology. 2011;53:396–405.
- Gaudieri S, Rauch A, Park LP, Freitas E, Herrmann S, et al. Evidence of viral adaptation to HLA class I-restricted immune pressure in chronic hepatitis C virus infection. J Virol. 2006;80:11094–11104.
- Timm J, Li B, Daniels MG, Bhattacharya T, Reyor LL, et al. Human leukocyte antigen-associated sequence polymorphisms in hepatitis C virus reveal reproducible immune responses and constraints on viral evolution. Hepatology. 2007;46:339–349.
- Busch MP, Glynn SA, Wright DJ, Hirschkorn D, Laycock ME, et al. Relative sensitivities of licensed nucleic acid amplification tests for detection of viremia in early human immunodeficiency virus and hepatitis C virus infection. Transfusion. 2005;45:1853–1863.
- Fischer W, Ganusov VV, Giorgi EE, Hraber PT, Keele BF, et al. Transmission of single HIV-1 genomes and dynamics of early immune escape revealed by ultra-deep sequencing. PLoS One. 2010;5:e12303.
- Haaland RE, Hawkins PA, Salazar-Gonzalez J, Johnson A, Tichacek A, et al. Inflammatory genital infections mitigate a severe genetic bottleneck in heterosexual transmission of subtype A and C HIV-1. PLoS Pathog. 2009;5:e1000274.
- Zhu T, Mo H, Wang N, Nam DS, Cao Y, et al. Genotypic and phenotypic characterization of HIV-1 patients with primary infection. Science. 1993;261:1179–1181.
- Fafi-Kremer S, Fofana I, Soulier E, Carolla P, Meuleman P, et al. Viral entry and escape from antibody-mediated neutralization influence hepatitis C virus reinfection in liver transplantation. J Exp Med. 2010;207:2019–2031.
- McCaffrey K, Boo I, Poumbourios P, Drummer HE. Expression and characterization of a minimal hepatitis C virus glycoprotein E2 core domain that retains CD81 binding. J Virol. 2007;81:9584–9590.
- Morel V, Fournier C, Francois C, Brochot E, Helle F, et al. Genetic recombination of the hepatitis C virus: clinical implications. J Viral Hepat. 2011;18:77–83.
- Holt KE, Parkhill J, Mazzoni CJ, Roumagnac P, Weill FX, et al. High-throughput sequencing provides insights into genome variation and evolution in Salmonella Typhi. Nat Genet. 2008;40:987–993.
- Stiffler JD, Nguyen M, Sohn JA, Liu C, Kaplan D, et al. Focal distribution of hepatitis C virus RNA in infected livers. PLoS One. 2009;4:e6661.
- Bartenschlager R, Lohmann V. Replication of hepatitis C virus. J Gen Virol. 2000;81:1631–1648.
- Ma Y, Yates J, Liang Y, Lemon SM, Yi M. NS3 helicase domains involved in infectious intracellular hepatitis C virus particle assembly. J Virol. 2008;82:7624–7639.
- Busch MP. Insights into the epidemiology, natural history and pathogenesis of hepatitis C virus infection from studies of infected donors and blood product recipients. Transfus Clin Biol. 2001;8:200–206.
- Glynn SA, Wright DJ, Kleinman SH, Hirschkorn D, Tu Y, et al. Dynamics of viremia in early hepatitis C virus infection. Transfusion. 2005;45:994–1002.
- Page-Shafer K, Pappalardo BL, Tobler LH, Phelps BH, Edlin BR, et al. Testing strategy to identify cases of acute hepatitis C virus (HCV) infection and to project HCV incidence rates. J Clin Microbiol. 2008;46:499–506.
- Pham ST, Bull RA, Bennett JM, Rawlinson WD, Dore GJ, et al. Frequent multiple hepatitis C virus infections among injection drug users in a prison setting. Hepatology. 2010;52:1564–1572.
- Zagordi O, Klein R, Daumer M, Beerenwinkel N. Error correction of next-generation sequencing data and reliable estimation of HIV quasispecies. Nucleic Acids Res. 2010;38:7400–7409.
- Zagordi O, Geyrhofer L, Roth V, Beerenwinkel N. Deep sequencing of a genetically heterogeneous sample: local haplotype reconstruction and read error correction. J Comput Biol. 2010;17:417–428.
- Koboldt DC, Chen K, Wylie T, Larson DE, McLellan MD, et al. VarScan: variant detection in massively parallel sequencing of individual and pooled samples. Bioinformatics. 2009;25:2283–2285.
- Giorgi EE, Funkhouser B, Athreya G, Perelson AS, Korber BT, et al. Estimating time since infection in early homogeneous HIV-1 samples using a poisson model. BMC Bioinformatics. 2010;11:532.
- Sanjuan R, Nebot MR, Chirico N, Mansky LM, Belshaw R. Viral mutation rates. J Virol. 2010;84:9733–9748.
- Tamura K, Dudley J, Nei M, Kumar S. MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol. 2007;24:1596–1599.
- Guindon S, Gascuel O. A simple, fast, and accurate algorithm to estimate large phylogenies by maximum likelihood. Syst Biol. 2003;52:696–704.
- Posada D, Buckley TR. Model selection and model averaging in phylogenetics: advantages of akaike information criterion and bayesian approaches over likelihood ratio tests. Syst Biol. 2004;53:793–808.
- Drummond AJ, Rambaut A. BEAST: Bayesian evolutionary analysis by sampling trees. BMC Evol Biol. 2007;7:214.
Source: PubMed